New catheter aims to zap AFib safely
NCT ID NCT05144503
First seen Feb 14, 2026 · Last updated Jun 12, 2026 · Updated 18 times
Summary
This study tests a new device, the SpherePVI catheter, to treat a heart rhythm problem called atrial fibrillation (AFib). About 100 adults with AFib will receive this treatment to see if it safely and effectively restores normal heart rhythm by isolating the veins that trigger the condition. The goal is to improve outcomes for people whose AFib hasn't been controlled by medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vilnius University Hospital
RECRUITINGVilnius, Lithuania
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.